Selenium supplementation in critically ill patients: A systematic review and meta-analysis

Journal of Critical Care

Volumn 29, Issue 1, 2014, Pages 150-156

  Landucci, Francesco ^a   Mancinelli, Paola ^a   De Gaudio, A Raffaele ^a   Virgili, Gianni ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antioxidant; Critical illness; Oxidative stress; Selenium

Indexed keywords

SELENIUM;

ADJUVANT THERAPY; CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; DRUG MEGADOSE; HEMODIALYSIS; HOSPITAL ACQUIRED PNEUMONIA; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY FUNCTION; LENGTH OF STAY; LOADING DRUG DOSE; LOW DRUG DOSE; META ANALYSIS; MONOTHERAPY; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SUPPLEMENTATION; SYSTEMATIC REVIEW;

ANTIOXIDANT; CRITICAL ILLNESS; OXIDATIVE STRESS; SELENIUM;

ANTIOXIDANTS; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELENIUM;

EID: 84890132618     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.08.017     Document Type: Review

References (34)

1. Gutteridge J.M., Mitchell J. Redox imbalance in the critically ill. Br Med Bull 1999, 55(1):49-75.
2. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991, 91(3C):31S-38S.
3. Sompol P., Ittarat W., Tangpong J., et al. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury. Neuroscience 2008, 153(1):120-130.
4. Goodyear-Bruch C., Pierce J.D. Oxidative stress in critically ill patient. Am J Crit Care 2002, 11(6):543-551.
5. Frost M.T., Wang Q., Moncada S., et al. Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol 2005, 288(2):R394-R400.
6. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007, 2(2):219-236.
7. Macdonald J., Galley H.F., Webster N.R. Oxidative stress and gene expression in sepsis. Br J Anaesth 2003, 90(2):221-232.
8. Forceville X. Seleno-enzymes and seleno-compounds: the two faces of selenium. Crit Care 2006, 10(6):180.
9. Manzanares W., Dhaliwal R., Jiang X., et al. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care 2012, 16(2):R66.
10. Heyland D.K., Dhaliwal R., Suchner U., et al. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005, 31(3):327-337.
11. Alhazzani W., Jacobi J., Sindi A., et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2013, 41:1555-1564.
12. Montoya C., Hernandez A., Antonio J., et al. Efecto antiinflamatorio del selenio en pacientes septicos. Rev Asoc Mex Med Crit y Ter Int 2009, 23:199-205.
13. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. The Cochrane Collaboration 2011, J.P.T. Higgins, S. Green (Eds.).
14. Andrews P.J., Avenell A., Noble D.W., et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011, 342:d1542.
15. Valenta J., Brodska H., Drabek T., et al. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 2011, 37(5):808-815.
16. Manzanares W., Biestro A., Torre M.H., et al. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med 2011, 37(7):1120-1127.
17. Angstwurm M.W., Engelmann L., Zimmermann T., et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007, 35(1):118-126.
18. Mishra V., Baines M., Perry S.E., et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 2007, 26(1):41-50.
19. Forceville X., Laviolle B., Annane D., et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 2007, 11(4):R73.
20. Angstwurm M.W., Schottdorf J., Schophol J., et al. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999, 27(9):1807-1813.
21. Zimmermann T., Albrecht S., Kühne H., et al. Substitution of selenium in septic patients. A prospective randomized study. Med Klin 1997, 3:3-4.
22. Carcillo J.A., Dean J.M., Holubkov R., et al. The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med 2012, 13(2):165-173.
23. Schneider A., Markowski A., Momma M., et al. Tolerability and efficacy of a low-volume enteral supplement containing key nutrients in the critically ill. Clin Nutr 2011, 30(5):599-603.
24. El-Attar M., Said M., El-Assal G., et al. Serum trace element levels in COPD patient: the relation between trace element supplementation and period of mechanical ventilation in a randomized controlled trial. Respirology 2009, 14(8):1180-1187.
25. Berger M.M., Soguel L., Shenkin A., et al. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care 2008, 12(4):R101.
26. Beale R.J., Sherry T., Lei K., et al. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med 2008, 36(1):131-144.
27. Berger M.M., Eggimann P., Heyland D.K., et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Crit Care 2006, 10(6):R153.
28. Berger M.M., Shenkin A., Revelly J.P., et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004, 80(2):410-416.
29. Bertolini G., Iapichino G., Radrizzani D., et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 2003, 29(5):834-840.
30. Berger M.M., Reymond M.J., Shenkin A., et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med 2001, 27(1):91-100.
31. Angstwurm M.W., Schopohl J., Gaertner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol 2004, 151(1):47-54.
32. Langan D., Higgins J.P.T., Gregory W., et al. Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol 2012, 65(5):511-519.
33. Berger M.M., Shenkin A. Selenium in intensive care: probably not a magic bullet but an important adjuvant therapy. Crit Care Med 2007, 35(1):306-307.
34. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013, 41(2):580-637.